Company Profile

XIAMEN SINOPEG BIOTECHCO., LTD
Year Established : 2011
Total Assets(USD) : choose not to disclose
Total Number of Staff : 40 to 49
Main Competitive Advantages : International Approvals/Standards,Production capacity,Large Product Line,Contract Manufacturing,Quality Service
  • Contact Person :
  • Fax:

 

SINOPEG is a fast-growing worldwide company dedicated to developing and manufacturing of poly(ethylene glycol) derivatives (PEGs) for drug pegylation, drug delivery, medical devices, bioenginerering, diagnostic assay development, polymer engineering, nanotechnology.

Based on proprietary technologies, SINOPEG is capable of supplying small to large quantities of high quality PEGs for customers worldwide. SINOPEG also provides custom synthesis of PEGs of various molecular weights (MW) and functionalities to facilitate and enhance growing industrial and academic uses.

SINOPEG operates a state-of-the-art GMP facility, designed and built specially for manufacturing PEG derivatives. Both non-GMP and GMP grade PEG products are available.

SINOPEG offers unique and bespoke services for drug PEGylation, polymer engineering, surface modification and technical consulting.

SINOPEG is in collaboration with a number of universities, institutions and pharmaceutical and biotech companies throughout the world.

PharmaSources Customer Service